UVB-induced decrease of p16/CDN2A expression in skin cancer patients

Pigment Cell Research

Volumn 14, Issue 3, 2001, Pages 201-205

  Krahn G ^a,b   Leiter, U ^b   Udart, M ^b   Kaskel, P ^a,b   Peter, R U ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Human skin; MED; Melanoma; P16; RT PCR; Squamous cell carcinoma; UVB

Indexed keywords

CANCER CELL; CARCINOGENESIS; CELL CYCLE; GENETIC REGULATION; PROTEIN EXPRESSION; PROTEIN P16; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0034811182     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2001.140310.x     Document Type: Article

References (32)

1. Detection of amplified oncogenes by differential polymerase chain reaction
2. Malignant melanoma: A genetic disease
3. A cell cycle regulator potentially involved in genesis of many tumor types
4. Deletions of the cyclin dependent kinase 4 inhibitor gene in multiple human cancers
5. Molecular genetics of familial cutaneous melanoma
6. Loss of the pl6INK4a and p15INK4b genes, as well as neighboring 9p21 markers in sporadic melanoma
7. P16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
8. CDKN2A mutation and deletion status u thin and thick primary melanoma
9. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression
10. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma
11. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions
12. Loss of expression of the p16 gene is frequent in malignant skin tumors
13. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanogenesis
14. UV activation of receptor tyrosine kinase activity
15. The mammalian UV response: Mechanism of DNA damage induced gene expression
16. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
17. Activation of telomerase and its association with Gl-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mice
18. UVB-induces atypical melanocytic lesions and melanoma in human skin
19. A CDKN2-1ike polymorphism in Xiphophorus LG V is associated with UV-B-induced melanoma formation in platyfish-swordtail hybrids
20. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study
21. Socioeconomic status, sunlight exposure and risk of malignant melanoma: The Western Canada Melanoma Study
22. Cutaneous melanoma in relation to intermittent and constant sun exposure: The Western Canada Melanoma Study
23. Melanoma and sun exposure: Contrasts between intermittent and chronic exposure
24. 2-phase cell cycle delay
25. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines
26. INK4/MTSI)gene in human melanoma cells: Relevance to tumor growth and metastasis
27. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
28. Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo
29. Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss
30. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E)
31. Involvement of p16/CDKN2A in cell cycle delays after low dose UV irradiation
32. Ultraviolet radiation induces p16 expression in human skin